Informationen
für ÄrztInnen:
Publikationen
| Titel | Autor | Download |
| Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials | R Jakesz et al www.thelancet.com Vol 369 May 19, 2007 1711 |
 |
| Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14 | Günther G Steger et al J Clin Oncol 25:2012-2018 Mai 2007 |
|
| Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients | F Fitzal et al Breast Cancer Res Treat (2007) 103:45–52 April, 2007 |
|
| An oncoplastic procedure for central and medio-cranial breast cancer | F Fitzal et al Ejso, April 2007 |
|
| An oncologic procedure for central and medio-cranical breats cancer | F Fitzal et al The Journal of Cancer Surgery, 04-2007 |
|
| Guidelines on the standards for the training of specialised health professionals dealing with breast cancer | R Jakesz et al EUROPEAN JOURNAL OF CANCER 4 3 ( 2 0 0 7 ) 6 6 0 –6 7 5 , Febr. 2007 |
|
| The use of a breast symmetry index for objective evaluation of breast cosmesis a | F. Fitzal et al The Breast, 01-2007 |
|
| LUMPECTOMY PLUS TAMOXIFEN OR ANASTROZOLE WITH OR WITHOUT WHOLE BREAST IRRADIATION IN WOMEN WITH FAVORABLE EARLY BREAST CANCER | M. Gnant et al Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 2, pp. 334–340, 2007 |
|
| Zoledronic Acid Effectively Prevents Cancer Treatment– Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group | Michael F.X. Gnant et al JOURNAL OF CLINICAL ONCOLOGY, Dec. 2006 |
|
| E. ectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormonesensitive early-stage breast cancer: a meta-analysis | M.Gnant et al Lancet Oncol 2006; 7: 991–96, Nov. 2005 |
|
| Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF | R. Jakesz et al Breast Cancer Res Treat (2007) 104:109–114 |
|
| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials | M. Gnant et al www.thelancet.com Vol 366 December 17/24/31, 2005 2087 |
|
| Trastuzumab in der adjuvanten Behandlung des Mammakarzinoms | R. Jakesz Arzt und Patient 2005 |
|
| Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer | G. Steger et al The new england journal of medicine established in 1812 october 20 , 2005 vol. 353 no. 16 |
|
| First—select the target: better choice of adjuvant treatments for breast cancer patients | R. Jakesz et al. Annals of Oncology 17: 1772–1776, 2006, Oct. 2006 |
|
| Retroviral targeting of proliferating of endothelial cells | R. Jakesz et al. Acto Biochimica Polonica, Sept. 2005 |
|
| A Case of Phyllodes Tumor with Focal Transition into Low-Grade Lymphangiosarcoma | T. Bachleitner-Hofmann et al Breast Care 2006;1:391–394 |
|
| Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells | P. Dubsky et al Breast Cancer Research 2006, 8 |
|
| VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival | Sebastian F. Schoppmann, et al Surgery 2006;139:839-46 |
|
| Preoperative core needle biopsy does not increase local recurrence rate in breast cancer patients | F. Fitzal et al Breast Cancer Research and Treatment, 2006 |
|
| Margin Status in Breast-Conserving Surgery of Early-Stage Breast Cancer | Sebastian F. Schoppmann, et al Breast Care 2006;1:000–000 |
|
| An update on ovarian suppression/ablation | R. Jakesz Int J Gynecol Cancer 2006;16 (Suppl. 2):511–514 |
|
| 25th Anniversary Edition: Human Dendritic Cell Subsets for or Vaccination accination | P. Dubsky et al Journal of Clinical Immunolo , Vol. l. 25, No. 6, November 2005 |
|
| Review Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 | R. Jakesz et al Annals of Oncology 16: 1569–1583, Nov. 2005 |
|
| Switching of postmenopausal women with endocrineresponsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial | R. Jakesz et al www.thelancet.com Vol 366 August 6, 2005 455 |
|
| Fulvestrant (_Faslodex_) in pre-treated patients with advanced breast cancer: A single-centre experience | G Steger et al European Journal of Cancer 41 (2005) 2655–2661 |
|
| Lymphangiogenesis, Inflammation and Metastasis | Sebastian F. Schoppmann ANTICANCER RESEARCH 25:June (2005) |
|
| Inosine 5V-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells | P. Dubsky et al Clinica Chimica Acta June 2005 |
|
| ABCSG Studie 6A Postadjuvante endokrine Brustkrebstherapie |
R. Jakesz Innere Medizin 05/05 |
|
| Brustdrüsenkarzinom | R. Jakesz et al 2005 |
|
| Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and Colorectal Cancer Study Group | R. Jakesz et al J Clin Oncol 23:1161-1168, 2005 |
|
| HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer | R. Jakesz et al ONCOLOGY REPORTS 14: 737-741, 2005 |
|
| Preoperative second-line chemotherapy induces objective responses in primary breast cancer | U. Pluschnig et al Wien Klin Wochenschr (2005) 117/1–2: 48–52 |
|
| Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer | Sebastian F. Schoppmann et al Ann Surg 2004;240: 306–312 |
|
| Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study | M. Rudas et al J Cancer Res Clin Oncol (2004) 130: 400–404 |
|
| E16. Amenorrhoea, aromatase inhibitors, tamoxifen or a combination in premenopausal women | R. Jakesz EJC Supplements Vol 2 No 9 (2004) 51-53 |
|
| The impact of progesterone receptor in prediction of complete pathological response to preoperative chemotherapy in primary breast cancer patients | M. Rudas et al Eur Surg (2004) 36/1: 41–45 |
|
| High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS | M. Rudas et al EJSO (2004) 30, 243–247 |
|
| Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer | M. Rudas et al Wien Klin Wochenschr (2004) 116/1–2: 26–31 |
|
| OVEREXPRESSION OF Id-1 IS ASSOCIATED WITH POOR CLINICAL OUTCOME IN NODE NEGATIVE BREAST CANCER | Sebastian F. Schoppmann, et al Int. J Cancer 104, 677-682 (2003) |
|
| Dendritic Cell-Based Vaccination in Solid Cancer | T. Bachleitner-Hofmann et al Journal of Clinival Oncology, Vol 21, No 1 (Januray 1) 2003 pp 135-142 |
|
| Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cells | T. Bachleitner-Hofmann et al 4997 BLOOD, 15 JUNE 2003 VOLUME 101, NUMBER 12 |
|
| Level of Id-1 Protein Expression Correlates with Poor Differentiation, Enhanced Malignant Potential, and More Aggressive Clinical Behavior of Epithelial Ovarian Tumors | Sebastian F. Schoppmann, et al Clinical Cancer Research, Vol 9 779-785, February 2003 |
|
| Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1and BRCA2gene | M. Gnant et al Langenbecks Arch Surg (2003) 388:38 |
|
| Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen | T. Bachleitner-Hofmann et al Clinical Cancer Research, Vol 8 3427-3472, November 2002 |
|
| Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis | Sebastian F. Schoppmann et al JAmerican Journal of Pathology, Vol 161 No. 3, September 2002 |
|
| Overexpression of Hypoxia-inducible Factor 1_ Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer | Sebastian F. Schoppmann, et al Clinical Cancer Research, Vol 8 1831-1837, June 2002 |
|
| Stimulation of Autologous Antitumor T-Cell Responses Against Medullary Thyroid Carcinoma Using Tumor Lysate-Pulsed Dendritic Cells | T. Bachleitner-Hofmann et al J Clin Endocrinol Metab 87: 1098–1104, 2002 |
|
| Young Age as an Independent Adverse oung Prognostic F Factor in Premenopausal P actor Patients atients with Breast Cancer | P. Dubsky et al Clinical Breast Cancer Cancer, Vol. 3, No. 1, 2002 |
|
| Lymphatic vessels and lymphangiogenesis in female cancer: Mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review) | Sebastian F. Schoppmann, et al Oncology Reports 9, 455-460, 2002 |
|
